# Trial to Evaluate CIS43LS in Healthy Adults

> **NCT04206332** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 71 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** VRC-MALMAB0100-00-AB
- **OTHER:** Plasmodium falciparum (P. falciparum) sporozoite challenge

## Key facts

- **NCT ID:** NCT04206332
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-07
- **Primary completion:** 2022-02-28
- **Final completion:** 2022-02-28
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04206332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04206332, "Trial to Evaluate CIS43LS in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04206332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*